malignant hypertension

Description

Malignant Hypertension: A Rare but Dangerous Condition

Malignant hypertension is a rare and severe form of high blood pressure that can cause immediate and irreversible damage to organs, particularly the kidneys, heart, brain, and eyes [14]. It is characterized by a sudden spike in blood pressure, typically exceeding 180/120 mmHg [12], which can lead to acute ischemic damage in one or more organs [12].

Causes of Malignant Hypertension

Uncontrolled high blood pressure is one of the main causes of malignant hypertension [9]. Other causes include adrenal disorders such as Conn's syndrome, Cushing's syndrome, pheochromocytoma, or a renin-secreting tumor, and central nervous system disorders like a brain bleed, stroke, or traumatic brain injury [9].

Symptoms of Malignant Hypertension

Malignant hypertension can cause new symptoms related to the eye or other organs, such as those mentioned in [13]. The sudden rise in blood pressure can also lead to damage to one or more organs, including the kidneys, heart, brain, and eyes [14].

Prevalence of Malignant Hypertension

Malignant hypertension is a rare disease, affecting approximately 1-2 people per 1 million [3]. It usually complicates uncontrolled chronic hypertension (1%) but can also be the consequence of acute secondary problems [3].

Therapeutic Challenges

Malignant hypertension requires immediate medical attention and treatment. The therapeutic challenges associated with this condition are discussed in [15], which highlights the need for future research directions.

References: [1] - Not available [2] - Not available [3] - Context result 3 [9] - Context result 9 [12] - Context result 12 [13] - Context result 13 [14] - Context result 14 [15] - Context result 15

Additional Characteristics

  • malignant hypertension
  • rare and severe form of high blood pressure
  • can cause immediate and irreversible damage to organs
  • kidneys, heart, brain, and eyes
  • uncontrolled high blood pressure
  • adrenal disorders (Conn's syndrome, Cushing's syndrome, pheochromocytoma, or a renin-secreting tumor)
  • central nervous system disorders (brain bleed, stroke, or traumatic brain injury)
  • damage to one or more organs (kidneys, heart, brain, and eyes)
  • rare disease
  • affecting approximately 1-2 people per 1 million

Signs and Symptoms

Malignant Hypertension Signs and Symptoms

Malignant hypertension is a medical emergency that requires immediate attention. The signs and symptoms can vary from person to person, but here are some common indicators:

  • Sudden vision problems: Blurred vision, double vision, or loss of vision in one eye [5][6]
  • Changes in mental status: Confusion, anxiety, decreased alertness, or altered consciousness [5][6]
  • Cardiac symptoms: Angina, myocardial infarction (heart attack), congestive heart failure, or pulmonary edema [7]
  • Eye exam changes: High blood pressure can cause changes in the eyes, including retinal hemorrhages, exudates, and papilledema [10][12]
  • Physical exam findings: Extremely high blood pressure, swelling in the lower legs and feet, abnormal heart sounds, and fluid in the lungs [10][12]
  • Nausea and vomiting: These symptoms can occur due to increased intracranial pressure caused by elevated blood pressure [14]

It's essential to seek medical attention immediately if you or someone you know is experiencing any of these symptoms. Malignant hypertension is a life-threatening condition that requires prompt treatment.

References:

  • [5] Mar 19, 2023 — Symptoms of Malignant Hypertension
  • [6] Oct 3, 2024 — Symptoms
  • [7] Aug 27, 2024 — The cardiac presentation of malignant hypertension
  • [10] Oct 3, 2024 — Symptoms
  • [12] If you get a very high blood pressure reading at home and don't have any symptoms, relax for a few minutes. Then check your blood pressure again.
  • [14] Nausea and vomiting occur in about 10-15% of patients with malignant hypertension.

Additional Symptoms

  • Nausea and vomiting
  • Changes in mental status
  • Sudden vision problems
  • Cardiac symptoms
  • Eye exam changes
  • Physical exam findings

Diagnostic Tests

Diagnostic Tests for Malignant Hypertension

Malignant hypertension, a severe form of high blood pressure, requires prompt diagnosis and treatment to prevent further damage to organs such as the heart, kidneys, and brain.

  • Initial Laboratory Studies: The first tests to order include:
    • Complete Blood Cell (CBC) count
    • Electrolytes (including calcium)
    • Blood Urea Nitrogen (BUN)
    • Creatinine These tests help assess the overall health of the patient and identify any potential complications [3].
  • Diagnostic Tests: Additional tests may be ordered to confirm the diagnosis, including:
    • Chest X-ray to detect signs of fluid retention in the lungs (pulmonary edema) [1]
    • ECG to monitor heart activity
    • Urinalysis with microscopy to check for kidney damage
    • CT scan of the head to diagnose intracranial hemorrhage or other complications [9]
  • Other Tests: Depending on the patient's symptoms and medical history, additional tests may be ordered, such as:
    • Cardiac enzymes (markers of heart damage)
    • Level of aldosterone (a hormone from the adrenal gland)
    • CT scan of the kidneys to assess renal artery stenosis [4]

Citation:

[1] - The types of tests you have

Additional Diagnostic Tests

  • Creatinine
  • Chest X-ray
  • Complete Blood Cell (CBC) count
  • ECG
  • Electrolytes (including calcium)
  • Blood Urea Nitrogen (BUN)
  • Urinalysis with microscopy
  • CT scan of the head
  • Cardiac enzymes
  • Level of aldosterone
  • CT scan of the kidneys

Treatment

Treatment Options for Malignant Hypertension

Malignant hypertension, also known as hypertensive emergency, requires immediate medical attention to prevent further damage to vital organs such as the brain, heart, kidneys, and eyes.

Medications Used in Treatment

The treatment of malignant hypertension involves the use of specific medications that can rapidly lower blood pressure. The following are some of the commonly used drugs:

  • Nitrovasodilators: These include nitroglycerin and nitroprusside, which provide nitric oxide to induce vasodilation (widening of blood vessels). [3][4]
  • Clevidipine: This is a calcium channel blocker that can be administered intravenously to lower blood pressure. [4]
  • Beta-blockers: Intravenous beta-blockers such as labetalol and propranolol are used to gradually reduce blood pressure. [10][11]
  • Renin-angiotensin system blockers: These seem to be the cornerstone of treatment for malignant hypertension, particularly in cases where there is severe damage to vital organs. [12]

Other Considerations

It's essential to note that the choice of medication depends on various factors, including the underlying cause of the condition, the severity of symptoms, and any pre-existing medical conditions.

In some cases, other medications may be used in conjunction with these primary treatments to manage complications such as heart failure or encephalopathy. [13]

Outcomes and Prognosis

The prognosis for patients with malignant hypertension is generally poor if left untreated. However, prompt recognition and treatment can significantly improve outcomes. [14][15]

Recommended Medications

  • Beta-blockers
  • Renin-angiotensin system blockers
  • Nitrovasodilators
  • clevidipine

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Malignant Hypertension

Malignant hypertension, also known as hypertensive emergency, can be challenging to diagnose due to its similarity with other conditions. The differential diagnosis involves identifying the presence of damage in at least three different target organs (kidney, heart, brain, and small vessels) and out-of-range elevation in systolic and diastolic blood pressure.

Key Conditions to Consider:

  • Thrombotic Thrombocytopenic Purpura (TTP): A rare blood disorder characterized by the formation of blood clots in small blood vessels throughout the body. TTP can present with similar symptoms to malignant hypertension, including thrombocytopenia and microangiopathic hemolytic anemia.
  • Thrombotic Microangiopathy (TMA): A condition involving the formation of blood clots in small blood vessels, leading to damage in multiple organs. TMA can be caused by various factors, including malignant hypertension.
  • Hypertensive Urgency: A condition characterized by severe high blood pressure without evidence of acute organ damage.

Diagnostic Criteria:

To diagnose malignant hypertension, the following criteria must be met:

  1. Severe elevation in systolic and diastolic blood pressure
  2. Presence of damage in at least three different target organs (kidney, heart, brain, and small vessels)
  3. Out-of-range elevation in systolic and diastolic blood pressure

Diagnostic Challenges:

Despite the presence of diagnostic criteria, diagnosing malignant hypertension can be challenging due to its similarity with other conditions. The differential diagnosis may require further evaluation, including plasma exchange and etiological screening.

References:

  • 1 August 27, 2024 - Differentiating malignant hypertension-induced thrombotic microangiopathy from thrombotic thrombocytopenic purpura.
  • 2 October 21, 2019 - An important pathological feature ... diagnostic criteria required are the presence of damage of at least three different target organs (kidney, heart, brain, and small vessels) and out-of-range elevation in systolic and diastolic blood pressure....
  • 4 The differential diagnosis with other TMA (TTP) may be difficult as a major part of the TMAa are associated with high blood pressure and ischemic organ damage. ... plasma exchange could be initiated until getting results from etiological screening.
  • 6 In this context, presence of severe hypertensive retinopathy triggers diagnosis of malignant hypertension. This is a consensus. Whether it is mandatory in presence of heart, kidney, brain damage, and/or thrombotic microangiopathy is debated, as is need for bilateral retinal involvement or presence of papilledema.
  • 8 August 27, 2024 - In a literature review, Khanal et al reported that factors more likely to be present in malignant hypertension-induced thrombotic microangiopathy are (1) a previous history of hypertension, (2) high mean arterial pressure, and (3) presence of end-organ damage.

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_7286
owl#annotatedSource
t393222
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:10824
core#notation
DOID:10824
oboInOwl#hasDbXref
UMLS_CUI:C0020540
IAO_0000115
A hypertension that is characterized by rapid onset of extremely high blood pressure.
rdf-schema#label
malignant hypertension
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
t393612
RO_0002452
http://purl.obolibrary.org/obo/SYMP_0020064
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.